Immunomodulatory Treatments for Myasthenia Gravis: Plasma Exchange, Intravenous Immunoglobulins and Semiselective Immunoadsorption

Κώδικας QR

Immunomodulatory Treatments for Myasthenia Gravis: Plasma Exchange, Intravenous Immunoglobulins and Semiselective Immunoadsorption

None

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Baggi, Fulvio, Antozzi, Carlo
Μορφή:	Ηλεκτρονική πηγή Κεφάλαιο βιβλίου
Γλώσσα:	Αγγλικά
Έκδοση:	IntechOpen 2012
Θέματα:	Health Sciences
Διαθέσιμο Online:	https://www.intechopen.com/chapters/26691
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια

Myasthenia gravis and nutrition
από: Merve Nur Uçak, κ.ά.
Έκδοση: (2025-07-01)

Myasthenia Gravis and pregnancy
από: Georgina Burke
Έκδοση: (2024-03-01)

Ocular Manifestations of Myasthenia Gravis
από: Pruitt, Joseph A., κ.ά.
Έκδοση: (2012)

IMMUNOPATHOGENESIS OF MYASTHENIA GRAVIS (REVIEW)
από: E. D. Gasymly
Έκδοση: (2018-06-01)

EPIDEMIOLOGICAL FEATURES OF MYASTHENIA GRAVIS
από: Yu. A. KHATKHE, κ.ά.
Έκδοση: (2018-02-01)

Myasthenia Gravis – Current Treatment Standards and Emerging Drugs
από: Musilek, Kamil, κ.ά.
Έκδοση: (2012)

Treatment Approaches for Bronchopulmonary Infection in Myasthenia Gravis Patients
από: V. I. Sokolova, κ.ά.
Έκδοση: (2020-05-01)

Efgartigimod following plasma exchange in the treatment of subjects with generalised myasthenia gravis: study protocol for a multicentre, three-arm, open-label study
από: Lu Zhang, κ.ά.
Έκδοση: (2025-08-01)

Clinical and immunological features and treatment of myasthenia gravis in the elderly (review)
από: T. M. Alekseeva, κ.ά.
Έκδοση: (2019-04-01)

National guidelines for diagnosis, treatment, and management of myasthenia gravis in Israel
από: Shahar Shelly, κ.ά.
Έκδοση: (2025-08-01)

Epidemiologic studies of myasthenia gravis: literature review
από: T. M. Alekseeva, κ.ά.
Έκδοση: (2018-10-01)

Serum cytokine profiles in patients with myasthenia gravis
από: Xuan Wu, κ.ά.
Έκδοση: (2025-07-01)

DIAGNOSIS AND TREATMENT OF NEW-ONSET MYASTHENIA GRAVIS IN CRITICALLY ILL PATIENTS
από: E. B. Vasilyeva, κ.ά.
Έκδοση: (2016-03-01)

Epidemiologic and populational aspects of myasthenia gravis in the Krasnodar Region
από: Yu. A. Khatkhe, κ.ά.
Έκδοση: (2018-04-01)

Diagnosis of sleepiness, fatigue and depression in patients with myasthenia gravis
από: O. A. Kreis, κ.ά.
Έκδοση: (2020-12-01)

MYASTHENIA GRAVIS AS A RISK FACTOR DURING PREGNANCY
από: A. A. Borshcheva, κ.ά.
Έκδοση: (2018-05-01)

Research of antibodies to the acetylcholine receptors in patients with myasthenia gravis
από: T. V. Romanova
Έκδοση: (2013-04-01)

Therapeutic Journey and Economic Burden of Patients with Myasthenia Gravis in Italy: Results of a Real-World Analysis
από: Valentina Perrone, κ.ά.
Έκδοση: (2025-01-01)

Current understanding of the rational diagnostics and treatment of acquired myasthenia gravis. Part 2: treatment
από: S. N. Bardakov, κ.ά.
Έκδοση: (2016-09-01)

Results of rehabilitation of myasthenia gravis patients with subclinical respiratory disturbances
από: Yu. N. Rushkevich, κ.ά.
Έκδοση: (2025-04-01)

Steroid myopathy in patients with myasthenia gravis: a literature review
από: S. A. Zaytsevskaya, κ.ά.
Έκδοση: (2024-09-01)

FDA HAS APPROVED FIRST FCRN-BLOCKER FOR MYASTHENIA GRAVIS
Έκδοση: (2025-07-01)

2 cases transformation myasthenia gravis to amyotrophic lateral sclerosis
από: A. G. Sanadze, κ.ά.
Έκδοση: (2015-02-01)

Analysis of clinical manifestations and diagnosis of late-onset myasthenia gravis
από: A. N. Khalmurzina, κ.ά.
Έκδοση: (2020-06-01)

Dyslipidemia in Myasthenia Gravis: A Systematic Review and Meta-Analysis
από: Vasileios Giannopapas, κ.ά.
Έκδοση: (2025-06-01)

INTRAVENOUS IMMUNOGLOBULIN IN PEDIATRICS
από: A.Yu. Shcherbina, κ.ά.
Έκδοση: (2010-07-01)

Positive experience of the usage of Rituximab in management of refractory myasthenia gravis in Russia
από: N. I. Shcherbakova, κ.ά.
Έκδοση: (2015-09-01)

SPECIFIC MANAGEMENT OF MYASTHENIA GRAVIS IN PATIENTS UNDERGOING ABDOMINAL CANCER SURGERIES
από: V. E. GRUZDEV, κ.ά.
Έκδοση: (2019-07-01)

The Association of Myasthenia Gravis with HLA class II Antigens in Iraqi Patients
από: Baghdad Science Journal
Έκδοση: (2013-03-01)

Pembrolizumab-induced myasthenia gravis with respiratory involvement and favorable clinical outcome
από: Cristoss Gregory, κ.ά.
Έκδοση: (2025-07-01)

Национален консенсус за диагностика и лечение на myasthenia gravis
από: Ivan Milanov, κ.ά.
Έκδοση: (2025-05-01)

Switching to subcutaneous zilucoplan from intravenous complement component 5 inhibitors in generalised myasthenia gravis: a phase IIIb, open-label study
από: Miriam Freimer, κ.ά.
Έκδοση: (2025-07-01)

Current aspects of the clinic, diagnosis and treatment of acquired myasthenia gravis (review). Part 1: diagnostics
από: S. N. Bardakov, κ.ά.
Έκδοση: (2016-06-01)

IMMUNOREGULATORY EFFECTS OF INTRAVENOUS IMMUNOGLOBULINS
από: S. A. Sel'kov, κ.ά.
Έκδοση: (2014-07-01)

Overlap of myasthenia gravis, myocarditis, and inflammatory myopathy secondary to immune checkpoint inhibitor (pembrolizumab) on a background of previously undiagnosed thymoma-associated acetylcholine receptor antibody-positive myasthenia gravis
από: O. V. Finleyson
Έκδοση: (2025-04-01)

Myasthenia Gravis with Anti-MuSK Antibodies: Clinical Features and Histopathological Changes
από: Angelini, Corrado, κ.ά.
Έκδοση: (2012)

Myasthenia Gravis: New Insights into the Effect of MuSK Antibodies and Acetylcholinesterase Inhibitors
από: Punga, Anna Rostedt
Έκδοση: (2011)

Thymoma-associated myasthenia gravis coexisting with myotonic dystrophy: a case report
από: Michiyo Miyawaki, κ.ά.
Έκδοση: (2021-07-01)

AI-based thematic exploration to understand patients with myasthenia gravis by serological subtype
από: Louis Jackson, κ.ά.
Έκδοση: (2025-07-01)

Case Report: Eculizumab in highly active myasthenia gravis complicated by severe infections
από: Yufei Deng, κ.ά.
Έκδοση: (2025-07-01)